Overview

A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes

Status:
Completed
Trial end date:
2015-05-11
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of the trial is to investigate the effects of semaglutide on ß-cell function in subjects with type 2 diabetes.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S